{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:16:14Z","timestamp":1781644574301,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"DOI":"10.1186\/s42358-026-00541-3","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:55:14Z","timestamp":1775123714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the prevalence of overactive bladder syndrome in patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-8032","authenticated-orcid":false,"given":"Derya","family":"Cirakoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2931-3927","authenticated-orcid":false,"given":"Ahmet","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"1","key":"541_CR1","doi-asserted-by":"publisher","first-page":"102020","DOI":"10.1016\/j.berh.2024.102020","volume":"39","author":"DP Misra","year":"2025","unstructured":"Misra DP. Clinical manifestations of rheumatoid arthritis, including comorbidities, complications, and long-term follow-up. Best Pract Res Clin Rheumatol. 2025;39(1):102020.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"541_CR2","first-page":"134","volume":"59","author":"R Leila","year":"2021","unstructured":"Leila R, Alia F, Khereddine MD, Ben Rhouma S, Saoussen M, Kmar O, et al. Lower urinary tract symptoms in rheumatoid arthritis and spondyloarthritis male patients versus controls. Rom J Intern Med. 2021;59(2):134\u201340.","journal-title":"Rom J Intern Med"},{"issue":"1","key":"541_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/bju.70043","volume":"137","author":"O Gross","year":"2026","unstructured":"Gross O, Averbeck MA, Musco S, Ph\u00e9 V, Vrijens D, Welk B, et al. BJUI Clinical Dilemma\u2019: the overactive bladder. BJU Int. 2026;137(1):18\u201325.","journal-title":"BJU Int"},{"issue":"8","key":"541_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00192-024-06029-2","volume":"36","author":"L Zhang","year":"2025","unstructured":"Zhang L, Cai N, Mo L, Tian X, Liu H, Yu B. Global Prevalence of Overactive Bladder: A Systematic Review and Meta-analysis. Int Urogynecol J. 2025;36(8):1547\u201366.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"541_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5213\/inj.2448390.195","volume":"29","author":"T Toprak","year":"2025","unstructured":"Toprak T, Ayribas B. A New Perspective on the Etiology of Overactive Bladder Syndrome-Could Overactive Bladder Syndrome Be Associated With Altered Perception of Somatic Sensations as a Result of Obsessive-Compulsive Disorder? A Case-Control Study. Int Neurourol J. 2025;29(1):48\u201355.","journal-title":"Int Neurourol J"},{"issue":"11","key":"541_CR6","doi-asserted-by":"publisher","first-page":"e0225455","DOI":"10.1371\/journal.pone.0225455","volume":"14","author":"CK Lee","year":"2019","unstructured":"Lee CK, Tsai CP, Liao TL, Huang WN, Chen YH, Lin CH, et al. Overactive bladder and bladder pain syndrome\/interstitial cystitis in primary Sj\u00f6gren\u2019s syndrome patients: A nationwide population-based study. PLoS ONE. 2019;14(11):e0225455.","journal-title":"PLoS ONE"},{"issue":"2","key":"541_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/03009740500395278","volume":"35","author":"KL Lee","year":"2006","unstructured":"Lee KL, Chen MY, Yeh JH, Huang SW, Tai HC, Yu HJ. Lower urinary tract symptoms in female patients with rheumatoid arthritis. Scand J Rheumatol. 2006;35(2):96\u2013101.","journal-title":"Scand J Rheumatol"},{"key":"541_CR8","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.2147\/IJGM.S333423","volume":"14","author":"F Abushamma","year":"2021","unstructured":"Abushamma F, Nassar N, Najjar SO, Hijaze SM, Koni A, Zyoud SH, et al. Lower Urinary Tract Symptoms Among Females with Rheumatoid Arthritis: A Prospective Cross-Sectional Study. Int J Gen Med. 2021;14:8427\u201335.","journal-title":"Int J Gen Med"},{"issue":"1","key":"541_CR9","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.neurop.2023.100112","volume":"3","author":"ME Fern\u00e1ndez Cuadros","year":"2023","unstructured":"Fern\u00e1ndez Cuadros ME, Mart\u00edn-Mart\u00edn LM, Albaladejo-Flor\u00edn MJ, P\u00e9rez-Moro OS, \u00c1lava-Rabasa S, Goizueta-San-Mart\u00edn G. Overactive bladder, lack of habituation, and central sensitisation: the sympathetic skin response as a possible diagnostic marker and neuromodulation as a treatment. Neurol Perspect. 2023;3(1):100112.","journal-title":"Neurol Perspect"},{"issue":"4","key":"541_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/nau.23060","volume":"36","author":"WS Reynolds","year":"2017","unstructured":"Reynolds WS, Mock S, Zhang X, Kaufman M, Wein A, Bruehl S, et al. Somatic syndromes and chronic pain in women with overactive bladder. Neurourol Urodyn. 2017;36(4):1113\u201318.","journal-title":"Neurourol Urodyn"},{"key":"541_CR11","doi-asserted-by":"publisher","first-page":"138464","DOI":"10.1016\/j.neulet.2025.138464","volume":"871","author":"J Chen","year":"2026","unstructured":"Chen J, Lai Y, Li W. Involvement of substance P\/NK1 receptor system in central sensitization in chronic pain. Neurosci Lett. 2026;871:138464.","journal-title":"Neurosci Lett"},{"issue":"7","key":"541_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41585-024-00967-8","volume":"22","author":"J Krhut","year":"2025","unstructured":"Krhut J, Kobber\u00f8 H, Kanaan R, Fode M, Poulsen M, Zvara P. The mechanism of action of neuromodulation in the treatment of overactive bladder. Nat Rev Urol. 2025;22(7):414\u201326.","journal-title":"Nat Rev Urol"},{"key":"541_CR13","doi-asserted-by":"crossref","unstructured":"Kurtulus D, Arkan K, Suceken FY, Akgol S, Can B. Assessment of overactive bladder in women with fibromyalgia presenting with lower urinary tract symptoms: a controlled clinical study. Neurourol Urodyn. 2025:1\u20136.","DOI":"10.1002\/nau.70206"},{"key":"541_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/0115733971309885241011105213","volume":"21","author":"I Berrichi","year":"2025","unstructured":"Berrichi I, Taik FZ, Haddani F, Soba N, Fourtassi M, Abourazzak FE. Prevalence and Associated Factors of Central Sensitization in Patients with Chronic Inflammatory Rheumatic Disease. Curr Rheumatol Rev. 2025;21:418\u201323.","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"541_CR15","doi-asserted-by":"publisher","first-page":"e70069","DOI":"10.1111\/1756-185X.70069","volume":"28","author":"Z Bazancir-Apaydin","year":"2025","unstructured":"Bazancir-Apaydin Z, Apaydin H, Armagan B, Orhan K, Erten S. The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross-Sectional Study. Int J Rheum Dis. 2025;28(1):e70069.","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"541_CR16","first-page":"980","volume":"40","author":"M Saitou","year":"2022","unstructured":"Saitou M, Noda K, Matsushita T, Ukichi T, Kurosaka D. Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory. Clin Exp Rheumatol. 2022;40(5):980\u201387.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"541_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003;42(2):244\u201357.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"541_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/art.20091","volume":"51","author":"AA K\u00fc\u00e7\u00fckdeveci","year":"2004","unstructured":"K\u00fc\u00e7\u00fckdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum. 2004;51(1):14\u20139.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"541_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00296-002-0247-2","volume":"23","author":"S Kutlay","year":"2003","unstructured":"Kutlay S, K\u00fc\u00e7\u00fckdeveci AA, G\u00f6n\u00fcl D, Tennant A. Adaptation and validation of the Turkish version of the Rheumatoid Arthritis Quality of Life Scale. Rheumatol Int. 2003;23(1):21\u20136.","journal-title":"Rheumatol Int"},{"issue":"4","key":"541_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.46497\/ArchRheumatol.2022.8665","volume":"36","author":"E D\u00fczce Kele\u015f","year":"2021","unstructured":"D\u00fczce Kele\u015f E, Birtane M, Ekuklu G, K\u0131l\u0131n\u00e7er C, \u00c7al\u0131yurt O, Ta\u015ftekin N, et al. Validity and reliability of the Turkish version of the central sensitization inventory. Arch Rheumatol. 2021;36(4):518\u201326.","journal-title":"Arch Rheumatol"},{"issue":"4","key":"541_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF02850085","volume":"22","author":"KS Coyne","year":"2005","unstructured":"Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG. Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther. 2005;22(4):381\u201394.","journal-title":"Adv Ther"},{"issue":"1","key":"541_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12894-024-01650-1","volume":"24","author":"N Erdik","year":"2024","unstructured":"Erdik N, Erdik A, Kizil D, Yavuzbilge G, Turk SM, Guneysu CA, et al. The relationship between neuropathic pain and lower urinary tract symptom scores in patients with primary Sj\u00f6gren\u2019s syndrome. BMC Urol. 2024;24(1):257.","journal-title":"BMC Urol"},{"issue":"1","key":"541_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0961203318811605","volume":"28","author":"E Pereira","year":"2019","unstructured":"Pereira E, Silva R, Rom\u00e3o VC, Neves M, Garcia R, Oliveira S, Brites J, et al. Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sj\u00f6gren syndrome. Lupus. 2019;28(1):27\u201333.","journal-title":"Lupus"},{"issue":"3","key":"541_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.12669\/pjms.41.3.8316","volume":"41","author":"AA Wagan","year":"2025","unstructured":"Wagan AA, Paras. Lower urinary tract symptoms and hematuria in Rheumatoid arthritis (LUTH-RA) study. Pak J Med Sci. 2025;41(3):876\u201379.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"541_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5213\/inj.2448002.001","volume":"28","author":"J Kwon","year":"2024","unstructured":"Kwon J, Kim DY, Cho KJ, Hashimoto M, Matsuoka K, Kamijo T, et al. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including \u03b23-Adrenoceptor Agonists -Basic Research Perspectives. Int Neurourol J. 2024;28(1):12\u201333.","journal-title":"Int Neurourol J"},{"issue":"1","key":"541_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12894-021-00809-4","volume":"21","author":"K Gill","year":"2021","unstructured":"Gill K, Horsley H, Swamy S, Khasriya R, Malone-Lee J. A prospective observational study of urinary cytokines and inflammatory response in patients with Overactive Bladder Syndrome. BMC Urol. 2021;21(1):39.","journal-title":"BMC Urol"},{"issue":"1","key":"541_CR27","doi-asserted-by":"publisher","first-page":"12579","DOI":"10.1038\/s41598-024-63448-3","volume":"14","author":"B Wei","year":"2024","unstructured":"Wei B, Zhao Y, Lin P, Qiu W, Wang S, Gu C, et al. The association between overactive bladder and systemic immunity-inflammation index: a cross-sectional study of NHANES 2005 to 2018. Sci Rep. 2024;14(1):12579.","journal-title":"Sci Rep"},{"issue":"1","key":"541_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s42358-025-00487-y","volume":"65","author":"MNGR de Pontes","year":"2025","unstructured":"de Pontes MNGR, de Jesus Sena D, de Melo AKG, Egypto DCS, Botelho LFB, de Sousa Braz A. Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital. Adv Rheumatol. 2025;65(1):52.","journal-title":"Adv Rheumatol"},{"issue":"4","key":"541_CR29","doi-asserted-by":"publisher","first-page":"e15159","DOI":"10.1111\/1756-185X.15159","volume":"27","author":"K Seki","year":"2024","unstructured":"Seki K, Imagama T, Seki T, Okazaki T, Sakai T. Central sensitivity syndrome affects the disease activity index and treatment satisfaction in patients with rheumatoid arthritis. Int J Rheum Dis. 2024;27(4):e15159.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"541_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/nau.25394","volume":"43","author":"ST Celenay","year":"2024","unstructured":"Celenay ST, Altay H, Bulbul SB, Oskay K. Black box in overactive bladder: Central sensitization and its relationship with urinary symptom severity and quality of life. Neurourol Urodyn. 2024;43(3):620\u201327.","journal-title":"Neurourol Urodyn"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-026-00541-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-026-00541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-026-00541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:55:31Z","timestamp":1779782131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42358-026-00541-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1186\/s42358-026-00541-3","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}